Evaluation of the efficacies of amphotericin B, posaconazole, voriconazole, and anidulafungin in a murine disseminated infection by the emerging opportunistic fungus Sarocladium (Acremonium) kiliense

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6265-6269

  Fernández Silva, Fabiola ^a   Capilla, Javier ^a   Mayayo, Emilio ^a   Sutton, Deanna A ^b   Hernández, Pilar ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; BETA GLUCAN; POSACONAZOLE; VORICONAZOLE;

ACREMONIUM KILIENSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FUNGUS; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOSIS; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; SAROCLADIUM KILIENSE; SURVIVAL RATE; SURVIVAL TIME;

ACREMONIUM; AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ECHINOCANDINS; MALE; MICE; MYCOSES; PYRIMIDINES; TRIAZOLES;

EID: 84887451723     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01484-13     Document Type: Article

References (46)

1. Summerbell RC, Gueidan C, Schroers HJ, de Hoog GS, Starink M, Rosete YA, Guarro J, Scott JA. 2011. Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud. Mycol. 68:139-162.
2. Das S, Saha R, Dar SA, Ramachandran VG. 2010. Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis. Mycopathologia 170:361-375.
3. Guarro J, Gams W, Pujol I, Gené J. 1997. Acremonium species: new emerging fungal opportunists-in vitro antifungal susceptibilities and review. Clin. Infect. Dis. 25:1222-1229.
4. Khan Z, Al-Obaid K, Ahmad S, Ghani AA, Joseph L, Chandy R. 2011. Acremonium kiliense: reappraisal of its clinical significance. J. Clin. Microbiol. 49:2342-2347.
5. Fridkin SK, Kremer FB, Bland LA, Padhye A, McNeil MM, Jarvis WR. 1996. Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir. Clin. Infect. Dis. 22:222-227.
6. Geyer AS, Fox LP, Husain S, Della-Latta P, Grossman ME. 2006. Acremonium mycetoma in a heart transplant recipient. J. Am. Acad. Dermatol. 55:1095-1100.
7. Grunwald MH, Cagnano M, Mosovich M, Halevy S. 1998. 1998. Cutaneous infection due to Acremonium. J. Eur. Acad. Dermatol. Venereol. 10:58-61.
8. Kan SF, Tsai TH, Hu CH, Lee WR. 2004. Cutaneous hyalohyphomycosis caused by Acremonium in an immunocompetent patient. Br. J. Dermatol. 150:789-790.
9. Kennedy SM, Shankland GS, Lee WR, Sekundo W. 1994. Keratitis due to the fungus Acremonium (Cephalosporium). Eye (Lond) 8(Pt 6):692-694.
10. McCormack JG, McIntyre PB, Tilse MH, Ellis DH. 1987. Mycetoma associated with Acremonium falciforme infection. Med. J. Aust. 147:187-188.
11. Milburn PB, Papayanopulos DM, Pomerantz BM. 1988. Mycetoma due to Acremonium falciforme. Int. J. Dermatol. 27:408-410.
12. Beaudreuil S, Buchler M, Al Najjar A, Bastides F, Francois M, Duong TH, Nivet H, Richard-Lenoble D, Lebranchu Y. 2003. Acute septic arthritis after kidney transplantation due to Acremonium. Nephrol. Dial. Transplant. 18:850-851.
13. Boltansky H, Kwon-Chung KJ, Macher AM, Gallin JI. 1984. Acremonium strictum-related pulmonary infection in a patient with chronic granulomatous disease. J. Infect. Dis. 149:653. doi:10.1093/infdis/149.4.653.
14. Brabender W, Ketcherside J, Hodges GR, Rengachary S, Barnes WG. 1985. Acremonium kiliense osteomyelitis of the calvarium. Neurosurgery 16:554-556.
15. Brown NM, Blundell EL, Chown SR, Warnock DW, Hill JA, Slade RR. 1992. Acremonium infection in a neutropenic patient. J. Infect. 25:73-76.
16. Chang YH, Huang LM, Hsueh PR, Hsiao CH, Peng SF, Yang RS, Lin KH. 2005. Acremonium pyomyositis in a pediatric patient with acute leukemia. Pediatr. Blood Cancer 44:521-524.
17. Anadolu R, Hilmioǧlu S, Oskay T, Boyvat A, Peksari Y, Gürgey E. 2001. Indolent Acremonium strictum infection in an immunocompetent patient. Int. J. Dermatol. 40:451-453.
18. Purnak T, Beyazit Y, Sahin GO, Shorbagi A, Akova M. 2011. A novel fungal pathogen under the spotlight Acremonium spp. associated fungaemia in an immunocompetent host. Mycoses 54:78-80.
19. Perdomo H, Sutton DA, García D, Fothergill AW, Cano J, Gené Summerbell JRC, Rinaldi MG, Guarro J. 2011. Spectrum of clinically relevant Acremonium species in the United States. J. Clin. Microbiol. 49: 243-256.
20. Fernández-Silva F, Capilla J, Mayayo E, Sutton DA, Guarro J. 3 July 2013. Experimental murine acremoniosis: an emerging opportunistic human infection. Med. Mycol. [Epub ahead of print.] doi:10.3109/13693786.2013.797610.
21. Keynan Y, Sprecher H, Weber G. 2007. Acremonium vertebral osteomyelitis: molecular diagnosis and response to voriconazole. Clin. Infect. Dis. 45:e5-e6.
22. Guarro J, Del Palacio A, Gené Cano JJ, González CG. 2009. A case of colonization of a prosthetic mitral valve by Acremonium strictum. Rev. Iberoam. Micol. 26:146-148.
23. Hitoto H, Pihet M, Weil B, Chabasse D, Bouchara JP, Rachieru-Sourisseau P. 2010. Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties. Mycopathologia 170:161-164.
24. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard-second edition. Document M38-A2. CLSI, Wayne, Pa.
25. Ortoneda M, Capilla J, Pastor FJ, Serena C, Guarro J. 2004. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn. Microbiol. Infect. Dis. 50:247-251.
26. Graybill JR. 2000. The role of murine models in the development of antifungal therapy for systemic mycoses. Drug Resist. Updat. 3:364-383.
27. Rodríguez MM, Pastor FJ, Calvo E, Salas V, Sutton DA, Guarro J. 2009. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob. Agents Chemother. 53:5022-5025.
28. Rodríguez MM, Pastor FJ, Salas V, Calvo E, Mayayo E, Guarro J. 2010. Experimental murine scedosporiosis: histopathology and azole treatment. Antimicrob. Agents Chemother. 54:3980-3984.
29. Calvo E, Pastor FJ, Mayayo E, Salas V, Guarro J. 2011. In vitro activity and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus. Antimicrob. Agents Chemother. 55:1290-1292.
30. Graybill JR, Najvar LK, Gonzalez GM, Hernandez S, Bocanegra R. 2003. Improving the mouse model for studying the efficacy of voriconazole. J. Antimicrob. Chemother. 51:1373-1376.
31. Herbrecht R, Letscher-Bru V, Fohrer C, Campos F, Natarajan-Ame S, Zamfir A, Waller J. 2002. Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 21:814-817.
32. Foell JL, Fischer M, Seibold M, Borneff-Lipp M, Wawer A, Horneff G, Burdach S. 2007. Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatr. Blood Cancer 49:858-861.
33. Yalaz M, Hilmioglu S, Metin D, Akisu M, Nart D, Cetin H, Ozturk C, Isik E, Kultursay N. 2003. Fatal disseminated Acremonium strictum infection in a preterm newborn: a very rare cause of neonatal septicaemia. J. Med. Microbiol. 52:835-837.
34. Novicki TJ, LaFe K, Bui L, Bui U, Geise R, Marr K, Cookson BT. 2003. Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis. J. Clin. Microbiol. 41: 2623-2628.
35. Schell WA, Perfect JR. 1996. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J. Clin. Microbiol. 34:1333-1336.
36. Jeffrey WR, Hernandez JE, Zarraga AL, Oley GE, Kitchen LW. 1993. Disseminated infection due to Acremonium species in a patient with Addison's disease. Clin. Infect. Dis. 16:170. doi:10.1093/clinids/16.1.170.
37. Tuon FF, Pozzi C, Penteado-Filho SR, Benvenutti R, Contieri FL. 2010. Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report. Rev. Soc. Bras. Med. Trop. 43:467-468.
38. Mattei D, Mordini N, Lo Nigro C, Gallamini A, Osenda M, Pugno F, Viscoli C. 2003. Successful treatment of Acremonium fungemia with voriconazole. Mycoses 46:511-514.
39. Guarro J. 2011. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J. Antimicrob. Chemother. 66:1447-1466.
40. Schell WA. 1995. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin. Lab. Med. 15:365-387.
41. Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. 2007. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1->3)-beta-Dglucan antigens. Eur. J. Clin. Microbiol. Infect. Dis. 26:755-766.
42. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. 2005. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659.
43. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. 2012. (1, 3)-β-D-Glucan as a prognostic marker of treatment response in invasive candidiasis. Clin. Infect. Dis. 55:521-526.
44. Khan ZU, Ahmad S, Theyyathel AM. 2008. Diagnostic value of DNA and (1->3)-beta-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum. J. Med. Microbiol. 57:36-42.
45. Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, Molina D, Olivo M, Graybill JR, Patterson TF. 2008. Assessment of serum (1-3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 52:1176-1178.
46. Lengerova M, Kocmanova I, Racil Z, Hrncirova K, Pospisilova S, Mayer J, Najvar LK, Wiederhold NP, Kirkpatrick WR, Patterson TF. 2012. Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1, 3)-β-D-glucan detection. J. Clin. Microbiol. 50:602-608.